Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh Do

Showing results (281-290 of 379) with videos related to

Pageof 38
Sort By:
Cancer|June 28, 2012
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancerAna M Gonzalez-Angulo, Huiqin Chen, Meghan S Karuturi, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Cancer Letters|April 29, 2025
Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreasChunliang Liu, Amber Mosley, Ehsan Irajizad, et al.
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
Annals of Surgery|May 1, 2002
Preoperative predictors of survival after resection of small hepatocellular carcinomasJeffrey D Wayne, Gregory Y Lauwers, Iwao Ikai, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Frontiers in Cardiovascular Medicine|September 20, 2024
New suggestions in radical surgical treatment of thromboembolism from the pulmonary artery stump after a Fontan operationDai Dac Tran, Long Hoang Vo, Huy Quang Bui, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.
Infectious Diseases and Therapy|November 28, 2022
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with CancerDenise Marie A Francisco, Liangliang Zhang, Ying Jiang, et al.
Pageof 38

Showing results (281-290 of 379) with videos related to

Sort By:
Pageof 38
Cancer|June 28, 2012
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancerAna M Gonzalez-Angulo, Huiqin Chen, Meghan S Karuturi, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Cancer Letters|April 29, 2025
Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreasChunliang Liu, Amber Mosley, Ehsan Irajizad, et al.
Breast Cancer Research : BCR|January 29, 2016
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancerEmily Powell, Jiansu Shao, Yuan Yuan, et al.
Annals of Surgery|May 1, 2002
Preoperative predictors of survival after resection of small hepatocellular carcinomasJeffrey D Wayne, Gregory Y Lauwers, Iwao Ikai, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Frontiers in Cardiovascular Medicine|September 20, 2024
New suggestions in radical surgical treatment of thromboembolism from the pulmonary artery stump after a Fontan operationDai Dac Tran, Long Hoang Vo, Huy Quang Bui, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.
Infectious Diseases and Therapy|November 28, 2022
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with CancerDenise Marie A Francisco, Liangliang Zhang, Ying Jiang, et al.
Pageof 38